Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology
Disease Category: Benign Prostatic Hyperplasia (Enlarged Prostate)
Trial Information
Phase III, Efficacy Study and Long Term Safety Assessment of Intermittent Therapy in Patients with Symptoms due to Benign Prostatic Hyperplasia (BPH)
One year placebo controlled efficacy study followed by
Open-label extension phase of intermittent dosage regimens of
intramuscular injections for the treatment of symptoms due to BPH
(Benign Prostatic Hyperplasia)
Patient Inclusion Criteria:
- Men, 50 years and older
- BPH, based on medical history
- Voiding Symptoms due to BPH
Patient Exclusion Criteria:
- Urgent need for Prostate Surgery
- Prior Surgical Treatment of Prostate or Bladder
- High PSA
Cheryl Ahlstrom, Recruitment Manager
South Florida Medical Research
21150 Biscayne Blvd. #300
Aventura, FL 33180
Phone: 305-931-8080 ext. 21
Fax: 305-931-8088
EMail: cahlstrom@southfloridamedicalresearch.co
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
